CPI STEM CELL THERAPY: A COST-BENEFIT ANALYSIS

Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Supporters often emphasize the potential for significant therapeutic gains, principally in diseases where conventional medications have proven limited. However, this is to consider the considerable financial burden associated with CPI stem cell therapy